IMODIUM Multi-Symptom Relief 125 mg/1
loperamide hydrochloride and dimethicone · TABLET · Kenvue Brands LLC
IMODIUM Multi-Symptom Relief is a prescription tablet containing loperamide hydrochloride and dimethicone at 125 mg/1, taken oral. Manufactured by Kenvue Brands LLC.
Key Facts
- Brand Name
- IMODIUM Multi-Symptom Relief
- Generic Name
- loperamide hydrochloride and dimethicone
- NDC Code (Product)
50580-338- Manufacturer
- Kenvue Brands LLC
- Strength
- 125 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- HUMAN OTC DRUG
- Application #
- NDA021140
- Drug Class
- Opioid Agonist [EPC]; Opioid Agonists [MoA]
- Marketing Start
- 07/01/2008
Recall History
Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.
Defective Container; damaged blister units
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is IMODIUM Multi-Symptom Relief used for?
IMODIUM Multi-Symptom Relief contains loperamide hydrochloride and dimethicone. It is a tablet taken oral. Consult your doctor for specific uses.
Is IMODIUM Multi-Symptom Relief a controlled substance?
IMODIUM Multi-Symptom Relief is not classified as a controlled substance by the DEA.
What is the generic name for IMODIUM Multi-Symptom Relief?
The generic name for IMODIUM Multi-Symptom Relief is loperamide hydrochloride and dimethicone. There are no other listed brand versions of loperamide hydrochloride and dimethicone.
What is the NDC code for IMODIUM Multi-Symptom Relief 125 mg/1?
The NDC (National Drug Code) for IMODIUM Multi-Symptom Relief 125 mg/1 is 50580-338, listed by Kenvue Brands LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)